Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2010
11/03/2010CN101297859B Chinese medicine preparation for treating duck virus hepatitis and preparation method thereof
11/03/2010CN101235039B Chemical total synthesis method for wedelolactone
11/03/2010CN101229251B Chinese traditional medicine for treating diarrhoea, bacillary dysentery and colonitis
11/03/2010CN101190239B Products containing LP lactic acid bacteria
11/03/2010CN101057615B Kidney strengthening tea
11/03/2010CN101052657B Method for production of indigestible dextrin comprising isoglucose
11/03/2010CN101043889B Use of A2b adenosine receptor antagonists in preparing medicine for promoting wound healing
11/03/2010CN101028043B Slow-settling swelling granular complex feed for large-yellow croaker scrod
11/03/2010CN101007155B Gastric-dissolved and enteric-dissolved pills of traditional Chinese medicine capable of strengthening spleen and nourishing intestine and its preparation method
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010US7824674 An antibody for treating Crohn's disease and ulcerative colitis, inhibit the transduction of biological activity of cytokine, B-cell differentiation factors
11/02/2010CA2686545C Deuterated morpholinyl compounds
11/02/2010CA2470391C N,n'-disubstituted piperazine compounds and their use as analgesics
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2437481C The use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2405741C Sodium salt of an azo derivative of 5-aminosalicylic acid
11/02/2010CA2360252C Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
11/02/2010CA2301136C Solid composition having reduced tooth erosion potential
10/2010
10/28/2010WO2010124235A1 Use adipose tissue-derived regenerative cells in the modulation of inflammation in the pancreas and in the kidney
10/28/2010WO2010124122A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010WO2010123930A2 Chemosensory receptor ligand-based therapies
10/28/2010WO2010123451A1 Sulphide bridged derivatives as modulators of mglur5
10/28/2010WO2010123155A1 Composition for use in the oral cavity
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123119A1 Therapeutic agent and screening method for inflammatory bowel disease
10/28/2010WO2010123111A1 1-menthyl (3r)-3-hydroxybutanoate, process for producing same, and composition containing same for stimulating sense
10/28/2010WO2010123110A1 Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense
10/28/2010WO2010123047A1 Crystal of benzoxazinone compound
10/28/2010WO2010123037A1 Agent for regulating composition ratio of intestinal bacterial flora
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010121404A1 Bear bile extract and preparation method and use thereof
10/28/2010WO2010121391A1 Solid food comprising dietary fiber and/or foodstuff rich in dietary fiber, preparation and use thereof
10/28/2010WO2010080577A3 Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation
10/28/2010WO2010065630A3 Compositions and methods for treating hepatic neoplasia
10/28/2010US20100274026 Virus therapeutic drug
10/28/2010US20100273895 Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the same
10/28/2010US20100273890 Identification of bacterial autoinducer and use in treating bacterial pathogenicity
10/28/2010US20100273881 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
10/28/2010US20100273868 R-Zileuton for Use in Conditions Associated with Increased 5-Lipoxygenase and/or Leukotriene Activity (EG Asthma)
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273847 Desferrioxamine conjugates, derivatives and analogues
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273829 Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal
10/28/2010US20100273825 Solid pharmaceutical composition containing solifenacin amorphous form
10/28/2010US20100273822 Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
10/28/2010US20100273820 Peripheral Phenolic Opioid Antagonist
10/28/2010US20100273816 Quinazoline Compounds
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273805 Sulphide bridged derivatives as modulators of mglur5 733
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273761 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100272838 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection
10/28/2010US20100272837 Traditional chinese medicinal compositions for treating depression , formulation thereof, method for preparing the same thereof
10/28/2010US20100272816 Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
10/28/2010US20100272808 Shell-and-Core Dosage Form Approaching Zero-Order Drug Release
10/28/2010US20100272798 Controlled release preparation
10/28/2010US20100272789 External medicine for treatment or prevention
10/28/2010US20100272781 Sugar Free Chewable Tablets
10/28/2010US20100272758 Viable non-toxic gram-negative bacteria
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272727 Compound for controlling appetite
10/28/2010US20100272718 Antibodies Against Human NKG2D and Uses Thereof
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272646 Method for inducing lymphoid tissue and modulating intestinal homeostasis
10/28/2010US20100270183 Stable digestive enzyme compositions
10/28/2010DE202010011400U1 Präbiotische Ballaststoffe, Kaffee, Granatapfelextrakt, Guarana und andere Pflanzenextrakte enthaltende Zusammensetzung Prebiotic fiber, coffee, pomegranate extract, guarana and other plant extracts containing composition
10/28/2010CA2759723A1 Colon lavage system
10/28/2010CA2759706A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2758976A1 Chemosensory receptor ligand-based therapies
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2756340A1 Bear bile extract and preparation method and use thereof
10/27/2010EP2243826A2 Mesenchymal stem cells and uses therefor
10/27/2010EP2243789A1 P.gingivalis antigenic composition
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243486A1 Adrenomedullin production enhancer
10/27/2010EP2124640B1 Glucose isomerase for use in the treatment of fructose intolerance
10/27/2010EP1305036B1 Nutritional composition
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN201612864U 壳聚糖包覆药物缓释微球 Chitosan microspheres coated drug delivery
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 1258